← SynDRA
VLX-1005
SynDRA canonical compound SYN0037817 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | ALOX12 |
| Mechanism of action | lipoxygenase inhibitor |
| Indication | thrombosis |
| Disease area | hematology |
All known targets
Mechanisms of action (all sources)
- ALOX12 INHIBITOR
- lipoxygenase inhibitor
- Inhibitor
Cross-references
Synonyms
- ML-355
- ML355
- A908037
- AC-36858
- AKOS030526578
- BCP28954
- BDBM50447175
- Benzenesulfonamide, N-2-benzothiazolyl-4-(((2-hydroxy-3-methoxyphenyl)methyl)amino)-
- BS-15552
- CHEBI:195557
- CHEMBL3113165
- CS-3351
- EX-A1987
- GTPL8752
- HY-12341
- JKU4XCC48Y
- ML355 free base
- N-(1,3-benzothiazol-2-yl)-4-[(2-hydroxy-3-methoxybenzyl)amino]benzenesulfonamide
- N-(1,3-benzothiazol-2-yl)-4-[(2-hydroxy-3-methoxyphenyl)methylamino]benzenesulfonamide
- N-(1,3-benzothiazol-2-yl)-4-{[(2-hydroxy-3-methoxyphenyl)methyl]amino}benzene-1-sulfonamide
- N-(Benzo[d]thiazol-2-yl)-4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide
- N-(Benzo[d]thiazol-2-yl)-4-(2-hydroxy-3-methoxybenzylamino)benzenesulfonamide
- N-2-Benzothiazolyl-4-(((2-hydroxy-3-methoxyphenyl)methyl)amino)benzenesulfonamide
- N-2-Benzothiazolyl-4-[[(2-hydroxy-3-methoxyphenyl)methyl]amino]benzenesulfonamide
- N-2-benzothiazolyl-4-[[(2-hydroxy-3-methoxyphenyl)methyl]amino]-benzenesulfonamide
- NCGC00263773-01
- NCGC00263773-03
- NCGC00263773-18
- Q27087172
- s6557
- SCHEMBL16646023
- UNII-JKU4XCC48Y
- VLX1005
- ZR5
- ML 355
- RefChem:194590
- orb1302931
- SCHEMBL29598551
Look up VLX-1005 in the interactive SynDRA portal →